Choriogonadotropin alfa biosimilar - Livzon Mabpharm

Drug Profile

Choriogonadotropin alfa biosimilar - Livzon Mabpharm

Alternative Names: LZM003

Latest Information Update: 28 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Livzon Mabpharm
  • Class Peptide hormones; Pituitary gonadotropins; Placental-hormone-vaccines; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Female infertility

Most Recent Events

  • 30 Nov 2016 Phase-I clinical trials in Female infertility (In volunteers) in China (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top